Search

Your search keyword '"Parfrey, Patrick"' showing total 1,206 results
Start Over Author "Parfrey, Patrick"
1,206 results on '"Parfrey, Patrick"'

1. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

Author

Koury, Mark J, Agarwal, Rajiv, Chertow, Glenn M, Eckardt, Kai‐Uwe, Fishbane, Steven, Ganz, Tomas, Haase, Volker H, Hanudel, Mark R, Parfrey, Patrick S, Pergola, Pablo E, Roy‐Chaudhury, Prabir, Tumlin, James A, Anders, Robert, Farag, Youssef MK, Luo, Wenli, Minga, Todd, Solinsky, Christine, Vargo, Dennis L, and Winkelmayer, Wolfgang C

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Kidney Disease, Hematology, Clinical Research, Evaluation of treatments and therapeutic interventions, Prevention of disease and conditions, and promotion of well-being, 3.3 Nutrition and chemoprevention, 6.1 Pharmaceuticals, Blood, Renal and urogenital, Anemia, Clinical Trials, Phase III as Topic, Darbepoetin alfa, Erythropoiesis, Erythropoietin, Ferritins, Glycine, Hematinics, Hemoglobins, Hepcidins, Humans, Iron, Picolinic Acids, Randomized Controlled Trials as Topic, Renal Insufficiency, Chronic, Transferrins, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
Abstract

Patients with chronic kidney disease (CKD) develop anemia largely because of inappropriately low erythropoietin (EPO) production and insufficient iron available to erythroid precursors. In four phase 3, randomized, open-label, clinical trials in dialysis-dependent and non-dialysis-dependent patients with CKD and anemia, the hypoxia-inducible factor prolyl hydroxylase inhibitor, vadadustat, was noninferior to the erythropoiesis-stimulating agent, darbepoetin alfa, in increasing and maintaining target hemoglobin concentrations. In these trials, vadadustat increased the concentrations of serum EPO, the numbers of circulating erythrocytes, and the numbers of circulating reticulocytes. Achieved hemoglobin concentrations were similar in patients treated with either vadadustat or darbepoetin alfa, but compared with patients receiving darbepoetin alfa, those receiving vadadustat had erythrocytes with increased mean corpuscular volume and mean corpuscular hemoglobin, while the red cell distribution width was decreased. Increased serum transferrin concentrations, as measured by total iron-binding capacity, combined with stable serum iron concentrations, resulted in decreased transferrin saturation in patients randomized to vadadustat compared with patients randomized to darbepoetin alfa. The decreases in transferrin saturation were associated with relatively greater declines in serum hepcidin and ferritin in patients receiving vadadustat compared with those receiving darbepoetin alfa. These results for serum transferrin saturation, hepcidin, ferritin, and erythrocyte indices were consistent with improved iron availability in the patients receiving vadadustat. Thus, overall, vadadustat had beneficial effects on three aspects of erythropoiesis in patients with anemia associated with CKD: increased endogenous EPO production, improved iron availability to erythroid cells, and increased reticulocytes in the circulation.

Published
2022

6. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Author

Abu-Alfa, Ali K., Afsar, Baris, Pai, Amy Barton, Besarab, Anatole, Moore, Geraldine Biddle, Casadevall, Nicole, Cases, Aleix, de Francisco, Angel, Eckardt, Kai-Uwe, Fishbane, Steven, Fried, Linda F., Ganz, Tomas, Ginzburg, Yelena Z., Gómez, Rafael, Goodnough, Lawrence T., Hamano, Takayuki, Hanudel, Mark R., Hao, Chuan-Ming, Iseki, Kunitoshi, Ix, Joachim H., Johansen, Kirsten L., Ketteler, Markus, Kovesdy, Csaba P., Leaf, David E., Macdougall, Iain C., Massy, Ziad A., McMahon, Lawrence P., Minutolo, Roberto, Nakanishi, Takeshi, Nemeth, Elizabeta, Obrador, Gregorio T., Parfrey, Patrick S., Park, Hyeong-Cheon, Pecoits-Filho, Roberto, Robinson, Bruce M., Roger, Simon D., Shah, Yatrik M., Spinowitz, Bruce S., Tanaka, Tetsuhiro, Tsukamoto, Yusuke, Tungsanga, Kriang, Walther, Carl P., Yee-Moon Wang, Angela, Wolf, Myles, Babitt, Jodie L., Eisenga, Michele F., Haase, Volker H., Kshirsagar, Abhijit V., Levin, Adeera, Locatelli, Francesco, Małyszko, Jolanta, Swinkels, Dorine W., Tarng, Der-Cherng, Cheung, Michael, Jadoul, Michel, Winkelmayer, Wolfgang C., and Drüeke, Tilman B.

Published
2021
Full Text
View/download PDF

10. Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Author

Macdougall, Iain C, Bircher, Andreas J, Eckardt, Kai-Uwe, Obrador, Gregorio T, Pollock, Carol A, Stenvinkel, Peter, Swinkels, Dorine W, Wanner, Christoph, Weiss, Günter, Chertow, Glenn M, Participants, Conference, Adamson, John W, Akizawa, Tadao, Anker, Stefan D, Auerbach, Michael, Bárány, Peter, Besarab, Anatole, Bhandari, Sunil, Cabantchik, Ioav, Collins, Alan J, Coyne, Daniel W, de Francisco, Ángel LM, Fishbane, Steven, Gaillard, Carlo AJM, Ganz, Tomas, Goldsmith, David J, Hershko, Chaim, Jankowska, Ewa A, Johansen, Kirsten L, Kalantar-Zadeh, Kamyar, Kalra, Philip A, Kasiske, Bertram L, Locatelli, Francesco, Małyszko, Jolanta, Mayer, Gert, McMahon, Lawrence P, Mikhail, Ashraf, Nemeth, Elizabeta, Pai, Amy Barton, Parfrey, Patrick S, Pecoits-Filho, Roberto, Roger, Simon D, Rostoker, Guy, Rottembourg, Jacques, Singh, Ajay K, Slotki, Itzchak, Spinowitz, Bruce S, Tarng, Der-Cherng, Tentori, Francesca, Toblli, Jorge E, Tsukamoto, Yusuke, Vaziri, Nosratola D, Winkelmayer, Wolfgang C, Wheeler, David C, and Zakharova, Elena

Subjects
Hematology, Digestive Diseases, Nutrition, Kidney Disease, Patient Safety, Liver Disease, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Renal and urogenital, Good Health and Well Being, Cardiovascular Diseases, Ferritins, Hematinics, Hemoglobins, Hepcidins, Humans, Hypersensitivity, Infections, Iron, Iron Deficiencies, Iron Overload, Oxidative Stress, Renal Insufficiency, Chronic, chronic kidney disease, hypersensitivity, infections, iron, overload, oxidative stress, Conference Participants, Clinical Sciences, Urology & Nephrology
Abstract

Before the introduction of erythropoiesis-stimulating agents (ESAs) in 1989, repeated transfusions given to patients with end-stage renal disease caused iron overload, and the need for supplemental iron was rare. However, with the widespread introduction of ESAs, it was recognized that supplemental iron was necessary to optimize hemoglobin response and allow reduction of the ESA dose for economic reasons and recent concerns about ESA safety. Iron supplementation was also found to be more efficacious via intravenous compared to oral administration, and the use of intravenous iron has escalated in recent years. The safety of various iron compounds has been of theoretical concern due to their potential to induce iron overload, oxidative stress, hypersensitivity reactions, and a permissive environment for infectious processes. Therefore, an expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects.

Published
2016

11. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

Author

Banerjee, Debasish, Briguori, Carlo, Chang, Tara I., Chen, Chien-Liang, deFilippi, Christopher R., Ding, Xiaoqiang, Ferro, Charles J., Gill, Jagbir, Gössl, Mario, Isbel, Nicole M., Ishii, Hideki, Jardine, Meg J., Kalra, Philip A., Laufer, Günther, Lentine, Krista L., Lobdell, Kevin, Lok, Charmaine E., London, Gérard M., Małyszko, Jolanta, Mark, Patrick B., Marwan, Mohamed, Nie, Yuxin, Parfrey, Patrick S., Pecoits-Filho, Roberto, Pilmore, Helen, Qunibi, Wajeh Y., Raggi, Paolo, Rattazzi, Marcello, Rossignol, Patrick, Ruturi, Josiah, Sabanayagam, Charumathi, Shanahan, Catherine M., Shroff, Gautam R., Shroff, Rukshana, Webster, Angela C., Weiner, Daniel E., Winther, Simon, Wiseman, Alexander C., Yip, Anthony, Zarbock, Alexander, Sarnak, Mark J., Amann, Kerstin, Bangalore, Sripal, Cavalcante, João L., Charytan, David M., Craig, Jonathan C., Gill, John S., Hlatky, Mark A., Jardine, Alan G., Landmesser, Ulf, Newby, L. Kristin, Herzog, Charles A., Cheung, Michael, Wheeler, David C., Winkelmayer, Wolfgang C., and Marwick, Thomas H.

Published
2019
Full Text
View/download PDF

12. Sustainability of an Enhanced Recovery After Surgery initiative for elective colorectal resections in a community hospital

Author

Norman, Alexander, Mahoney, Krista, Ballah, Erin, Pridham, Jeremy, Smith, Chris, and Parfrey, Patrick

Subjects
Mortality -- Canada, Sustainable development -- Comparative analysis, Health, Health care industry
Abstract

Background: In March 2016, an Enhanced Recovery After Surgery (ERAS) initiative was implemented for all elective colorectal resections at an urban hospital in St. John's, Newfoundland and Labrador, Canada. An ERAS coordinator supervised and enforced guideline compliance for 6 months. The aim of this study was to evaluate the sustainability of the ERAS program after supervision of guideline compliance was eliminated. Methods: Patient outcomes and guideline compliance were compared between surgeries performed under standard practice (April 2014 to March 2015) and those performed during and after the implementation of the ERAS initiative (March 2016 to August 2016 was the implementation phase and September 2016 to February 2017 was the sustainability phase). Results: Hospital length of stay decreased from 7.26 days at baseline to 5.44 days during the implementation phase of the ERAS program (p < 0.001). There was no significant difference between length of stay at baseline and during the 6-month sustainability phase of the ERAS program (7.10 d). There were no significant differences in rates of readmission or mortality during and after implementation. Rate of ileus decreased significantly from 13.8% during the implementation phase to 4.6% during the sustainability phase (p = 0.036). Total guideline compliance increased from 52.2% at baseline to 80.7% during the implementation phase (p < 0.001), and decreased to 74.7% during the sustainability phase (p < 0.001). Adherence to postoperative guidelines regressed: 79.2% in the implementation phase and 68.6% in the sustainability phase (p < 0.001). Conclusion: Hospital length of stay decreased when the ERAS program was implemented and the ERAS coordinator was present on the surgical ward. Methods for sustaining guideline implementation are vital to the success of similar programs in the future. Contexte : En mars 2016, une initiative de recuperation amelioree apres la chirurgie (RAAC) a ete mise en place pour toutes les resections colorectales electives effectuees dans un h[delta]pital urbain de St. John's, a Terre-Neuve-et-Labrador, au Canada. Un coordonnateur du projet de RAAC a supervise l'application des directives pendant 6 mois. Cette etude visait a evaluer la viabilite du programme une fois que l'application des directives n'etait plus surveillee. Methodes : Nous avons compare les issues pour les patients et le respect des directives pour les chirurgies realisees selon les pratiques habituelles (avril 2014 a mars 2015) et pour celles realisees pendant et apres l'adoption du programme de RAAC (mars 2016 a aout 2016--mise en ceuvre--et septembre 2016 a fevrier 2017--evaluation de la viabilite). Resultats : La duree du sejour a l'h[delta]pital est passee de 7,26 jours a 5,44 jours pendant la phase de mise en ceuvre du programme (p < 0,001). Il n'y avait pas de difference significative entre la duree du sejour au debut du programme et pendant les 6 mois de la phase d'evaluation de la viabilite (7,10 jours). Les taux de readmission et de mortalite avant et apres la mise en place du programme n'ont pas change de maniere significative. Le taux d'ileus a connu une baisse significative, passant de 13,8 % pendant la phase de mise en ceuvre a 4,6 % pendant l'evaluation de la viabilite (p = 0,036). Le respect des directives est passe de 52,2 % au debut de la mise en ceuvre a 80,7 % pendant cette meme phase (p < 0,001), pour ensuite descendre a 74,7 % pendant la phase suivante (p < 0,001). Le respect de lignes directrices postoperatoires a regresse : il etait de 79,2 % pendant la phase de mise en ceuvre et de 68,6 % pendant la phase d'evaluation de la viabilite (p < 0,001). Conclusion : La duree des sejours a l'hopital a augmente apres l'adoption du programme de RAAC, lorsque le coordonnateur du programme etait present. Les methodes de maintien des lignes directrices apres leur adoption seront cruciales au succes de programmes similaires a l'avenir., Enhanced Recovery After Surgery (ERAS) guidelines are best practice guidelines that direct the perioperative pathway, (1) and they have been shown to improve patient outcomes after major surgery. (2) Records [...]

Published
2020
Full Text
View/download PDF

23. Discovery of common and rare genetic risk variants for colorectal cancer

Author

Huyghe, Jeroen R., Bien, Stephanie A., Harrison, Tabitha A., Kang, Hyun Min, Chen, Sai, Schmit, Stephanie L., Conti, David V., Qu, Conghui, Jeon, Jihyoun, Edlund, Christopher K., Greenside, Peyton, Wainberg, Michael, Schumacher, Fredrick R., Smith, Joshua D., Levine, David M., Nelson, Sarah C., Sinnott-Armstrong, Nasa A., Albanes, Demetrius, Alonso, M. Henar, Anderson, Kristin, Arnau-Collell, Coral, Arndt, Volker, Bamia, Christina, Banbury, Barbara L., Baron, John A., Berndt, Sonja I., Bézieau, Stéphane, Bishop, D. Timothy, Boehm, Juergen, Boeing, Heiner, Brenner, Hermann, Brezina, Stefanie, Buch, Stephan, Buchanan, Daniel D., Burnett-Hartman, Andrea, Butterbach, Katja, Caan, Bette J., Campbell, Peter T., Carlson, Christopher S., Castellví-Bel, Sergi, Chan, Andrew T., Chang-Claude, Jenny, Chanock, Stephen J., Chirlaque, Maria-Dolores, Cho, Sang Hee, Connolly, Charles M., Cross, Amanda J., Cuk, Katarina, Curtis, Keith R., de la Chapelle, Albert, Doheny, Kimberly F., Duggan, David, Easton, Douglas F., Elias, Sjoerd G., Elliott, Faye, English, Dallas R., Feskens, Edith J. M., Figueiredo, Jane C., Fischer, Rocky, FitzGerald, Liesel M., Forman, David, Gala, Manish, Gallinger, Steven, Gauderman, W. James, Giles, Graham G., Gillanders, Elizabeth, Gong, Jian, Goodman, Phyllis J., Grady, William M., Grove, John S., Gsur, Andrea, Gunter, Marc J., Haile, Robert W., Hampe, Jochen, Hampel, Heather, Harlid, Sophia, Hayes, Richard B., Hofer, Philipp, Hoffmeister, Michael, Hopper, John L., Hsu, Wan-Ling, Huang, Wen-Yi, Hudson, Thomas J., Hunter, David J., Ibañez-Sanz, Gemma, Idos, Gregory E., Ingersoll, Roxann, Jackson, Rebecca D., Jacobs, Eric J., Jenkins, Mark A., Joshi, Amit D., Joshu, Corinne E., Keku, Temitope O., Key, Timothy J., Kim, Hyeong Rok, Kobayashi, Emiko, Kolonel, Laurence N., Kooperberg, Charles, Kühn, Tilman, Küry, Sébastien, Kweon, Sun-Seog, Larsson, Susanna C., Laurie, Cecelia A., Le Marchand, Loic, Leal, Suzanne M., Lee, Soo Chin, Lejbkowicz, Flavio, Lemire, Mathieu, Li, Christopher I., Li, Li, Lieb, Wolfgang, Lin, Yi, Lindblom, Annika, Lindor, Noralane M., Ling, Hua, Louie, Tin L., Männistö, Satu, Markowitz, Sanford D., Martín, Vicente, Masala, Giovanna, McNeil, Caroline E., Melas, Marilena, Milne, Roger L., Moreno, Lorena, Murphy, Neil, Myte, Robin, Naccarati, Alessio, Newcomb, Polly A., Offit, Kenneth, Ogino, Shuji, Onland-Moret, N. Charlotte, Pardini, Barbara, Parfrey, Patrick S., Pearlman, Rachel, Perduca, Vittorio, Pharoah, Paul D. P., Pinchev, Mila, Platz, Elizabeth A., Prentice, Ross L., Pugh, Elizabeth, Raskin, Leon, Rennert, Gad, Rennert, Hedy S., Riboli, Elio, Rodríguez-Barranco, Miguel, Romm, Jane, Sakoda, Lori C., Schafmayer, Clemens, Schoen, Robert E., Seminara, Daniela, Shah, Mitul, Shelford, Tameka, Shin, Min-Ho, Shulman, Katerina, Sieri, Sabina, Slattery, Martha L., Southey, Melissa C., Stadler, Zsofia K., Stegmaier, Christa, Su, Yu-Ru, Tangen, Catherine M., Thibodeau, Stephen N., Thomas, Duncan C., Thomas, Sushma S., Toland, Amanda E., Trichopoulou, Antonia, Ulrich, Cornelia M., Van Den Berg, David J., van Duijnhoven, Franzel J. B., Van Guelpen, Bethany, van Kranen, Henk, Vijai, Joseph, Visvanathan, Kala, Vodicka, Pavel, Vodickova, Ludmila, Vymetalkova, Veronika, Weigl, Korbinian, Weinstein, Stephanie J., White, Emily, Win, Aung Ko, Wolf, C. Roland, Wolk, Alicja, Woods, Michael O., Wu, Anna H., Zaidi, Syed H., Zanke, Brent W., Zhang, Qing, Zheng, Wei, Scacheri, Peter C., Potter, John D., Bassik, Michael C., Kundaje, Anshul, Casey, Graham, Moreno, Victor, Abecasis, Goncalo R., Nickerson, Deborah A., Gruber, Stephen B., Hsu, Li, and Peters, Ulrike

Published
2019
Full Text
View/download PDF

24. Meta-analysis of new genome-wide association studies of colorectal cancer risk

Author

Peters, Ulrike, Hutter, Carolyn M, Hsu, Li, Schumacher, Fredrick R, Conti, David V, Carlson, Christopher S, Edlund, Christopher K, Haile, Robert W, Gallinger, Steven, Zanke, Brent W, Lemire, Mathieu, Rangrej, Jagadish, Vijayaraghavan, Raakhee, Chan, Andrew T, Hazra, Aditi, Hunter, David J, Ma, Jing, Fuchs, Charles S, Giovannucci, Edward L, Kraft, Peter, Liu, Yan, Chen, Lin, Jiao, Shuo, Makar, Karen W, Taverna, Darin, Gruber, Stephen B, Rennert, Gad, Moreno, Victor, Ulrich, Cornelia M, Woods, Michael O, Green, Roger C, Parfrey, Patrick S, Prentice, Ross L, Kooperberg, Charles, Jackson, Rebecca D, LaCroix, Andrea Z, Caan, Bette J, Hayes, Richard B, Berndt, Sonja I, Chanock, Stephen J, Schoen, Robert E, Chang-Claude, Jenny, Hoffmeister, Michael, Brenner, Hermann, Frank, Bernd, Bézieau, Stéphane, Küry, Sébastien, Slattery, Martha L, Hopper, John L, Jenkins, Mark A, Le Marchand, Loic, Lindor, Noralane M, Newcomb, Polly A, Seminara, Daniela, Hudson, Thomas J, Duggan, David J, Potter, John D, and Casey, Graham

Subjects
Biological Sciences, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Genetics, Colo-Rectal Cancer, Aging, Human Genome, Cancer, Prevention, Digestive Diseases, 2.1 Biological and endogenous factors, Aetiology, Colorectal Neoplasms, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Male, Odds Ratio, Polymorphism, Single Nucleotide, Risk Factors, Complementary and Alternative Medicine, Paediatrics and Reproductive Medicine, Genetics & Heredity, Reproductive medicine
Abstract

Colorectal cancer is the second leading cause of cancer death in developed countries. Genome-wide association studies (GWAS) have successfully identified novel susceptibility loci for colorectal cancer. To follow up on these findings, and try to identify novel colorectal cancer susceptibility loci, we present results for GWAS of colorectal cancer (2,906 cases, 3,416 controls) that have not previously published main associations. Specifically, we calculated odds ratios and 95% confidence intervals using log-additive models for each study. In order to improve our power to detect novel colorectal cancer susceptibility loci, we performed a meta-analysis combining the results across studies. We selected the most statistically significant single nucleotide polymorphisms (SNPs) for replication using ten independent studies (8,161 cases and 9,101 controls). We again used a meta-analysis to summarize results for the replication studies alone, and for a combined analysis of GWAS and replication studies. We measured ten SNPs previously identified in colorectal cancer susceptibility loci and found eight to be associated with colorectal cancer (p value range 0.02 to 1.8 × 10(-8)). When we excluded studies that have previously published on these SNPs, five SNPs remained significant at p

Published
2012

28. Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Non-Dialysis Chronic Kidney Disease Patients: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients

Author

Parfrey, Patrick S., primary, Burke, Steven K., additional, Chertow, Glenn M., additional, Eckardt, Kai-Uwe, additional, Jardine, Alan G., additional, Lewis, Eldrin F., additional, Luo, Wenli, additional, Matsushita, Kunihiro, additional, McCullough, Peter A., additional, Minga, Todd, additional, and Winkelmayer, Wolfgang C., additional

Published
2023
Full Text
View/download PDF

29. Safety Endpoints With Vaadustat Versus Darbepoetin Alfa in Nondialysis CKD Patients: A Post hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients

Author

Winkelmayer, Wolfgang C., primary, Arnold, Susan, additional, Burke, Steven K., additional, Chertow, Glenn M., additional, Eckardt, Kai-Uwe, additional, Jardine, Alan G., additional, Lewis, Eldrin F., additional, Luo, Wenli, additional, Matsushita, Kunihiro, additional, McCullough, Peter A., additional, Minga, Todd, additional, and Parfrey, Patrick S., additional

Published
2023
Full Text
View/download PDF

30. Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

Author

Sarnak, Mark J, primary, Agarwal, Rajiv, additional, Boudville, Neil, additional, Chowdhury, Pradip C P, additional, Eckardt, Kai-Uwe, additional, Gonzalez, Carlos R, additional, Kooienga, Laura A, additional, Koury, Mark J, additional, Ntoso, Kwabena A, additional, Luo, Wenli, additional, Parfrey, Patrick S, additional, Vargo, Dennis L, additional, Winkelmayer, Wolfgang C, additional, Zhang, Zhiqun, additional, and Chertow, Glenn M, additional

Published
2023
Full Text
View/download PDF

31. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

Author

Seyed Khoei, Nazlisadat, Jenab, Mazda, Murphy, Neil, Banbury, Barbara L., Carreras-Torres, Robert, Viallon, Vivian, Kühn, Tilman, Bueno-de-Mesquita, Bas, Aleksandrova, Krasimira, Cross, Amanda J., Weiderpass, Elisabete, Stepien, Magdalena, Bulmer, Andrew, Tjønneland, Anne, Boutron-Ruault, Marie-Christine, Severi, Gianluca, Carbonnel, Franck, Katzke, Verena, Boeing, Heiner, Bergmann, Manuela M., Trichopoulou, Antonia, Karakatsani, Anna, Martimianaki, Georgia, Palli, Domenico, Tagliabue, Giovanna, Panico, Salvatore, Tumino, Rosario, Sacerdote, Carlotta, Skeie, Guri, Merino, Susana, Bonet, Catalina, Rodríguez-Barranco, Miguel, Gil, Leire, Chirlaque, Maria-Dolores, Ardanaz, Eva, Myte, Robin, Hultdin, Johan, Perez-Cornago, Aurora, Aune, Dagfinn, Tsilidis, Konstantinos K., Albanes, Demetrius, Baron, John A., Berndt, Sonja I., Bézieau, Stéphane, Brenner, Hermann, Campbell, Peter T., Casey, Graham, Chan, Andrew T., Chang-Claude, Jenny, Chanock, Stephen J., Cotterchio, Michelle, Gallinger, Steven, Gruber, Stephen B., Haile, Robert W., Hampe, Jochen, Hoffmeister, Michael, Hopper, John L., Hsu, Li, Huyghe, Jeroen R., Jenkins, Mark A., Joshi, Amit D., Kampman, Ellen, Larsson, Susanna C., Le Marchand, Loic, Li, Christopher I., Li, Li, Lindblom, Annika, Lindor, Noralane M., Martín, Vicente, Moreno, Victor, Newcomb, Polly A., Offit, Kenneth, Ogino, Shuji, Parfrey, Patrick S., Pharoah, Paul D. P., Rennert, Gad, Sakoda, Lori C., Schafmayer, Clemens, Schmit, Stephanie L., Schoen, Robert E., Slattery, Martha L., Thibodeau, Stephen N., Ulrich, Cornelia M., van Duijnhoven, Franzel J. B., Weigl, Korbinian, Weinstein, Stephanie J., White, Emily, Wolk, Alicja, Woods, Michael O., Wu, Anna H., Zhang, Xuehong, Ferrari, Pietro, Anton, Gabriele, Peters, Annette, Peters, Ulrike, Gunter, Marc J., Wagner, Karl-Heinz, and Freisling, Heinz

Published
2020
Full Text
View/download PDF

36. Supplementary Information from High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes

Author

Woods, Michael O., primary, Hyde, Angela J., primary, Curtis, Fiona K., primary, Stuckless, Susan, primary, Green, Jane S., primary, Pollett, Aaron F., primary, Robb, J. Desmond, primary, Green, Roger C., primary, Croitoru, Marina E., primary, Careen, Amanda, primary, Chaulk, Jason A.W., primary, Jegathesan, Jegan, primary, McLaughlin, John R., primary, Gallinger, Steven S., primary, Younghusband, H. Banfield, primary, Bapat, Bharati V., primary, and Parfrey, Patrick S., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table S7 from Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies

Author

Hidaka, Akihisa, primary, Harrison, Tabitha A., primary, Cao, Yin, primary, Sakoda, Lori C., primary, Barfield, Richard, primary, Giannakis, Marios, primary, Song, Mingyang, primary, Phipps, Amanda I., primary, Figueiredo, Jane C., primary, Zaidi, Syed H., primary, Toland, Amanda E., primary, Amitay, Efrat L., primary, Berndt, Sonja I., primary, Borozan, Ivan, primary, Chan, Andrew T., primary, Gallinger, Steven, primary, Gunter, Marc J., primary, Guinter, Mark A., primary, Harlid, Sophia, primary, Hampel, Heather, primary, Jenkins, Mark A., primary, Lin, Yi, primary, Moreno, Victor, primary, Newcomb, Polly A., primary, Nishihara, Reiko, primary, Ogino, Shuji, primary, Obón-Santacana, Mireia, primary, Parfrey, Patrick S., primary, Potter, John D., primary, Slattery, Martha L., primary, Steinfelder, Robert S., primary, Um, Caroline Y., primary, Wang, Xiaoliang, primary, Woods, Michael O., primary, Van Guelpen, Bethany, primary, Thibodeau, Stephen N., primary, Hoffmeister, Michael, primary, Sun, Wei, primary, Hsu, Li, primary, Buchanan, Daniel D., primary, Campbell, Peter T., primary, and Peters, Ulrike, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Text from Intake of Dietary Fruit, Vegetables, and Fiber and Risk of Colorectal Cancer According to Molecular Subtypes: A Pooled Analysis of 9 Studies

Author

Hidaka, Akihisa, primary, Harrison, Tabitha A., primary, Cao, Yin, primary, Sakoda, Lori C., primary, Barfield, Richard, primary, Giannakis, Marios, primary, Song, Mingyang, primary, Phipps, Amanda I., primary, Figueiredo, Jane C., primary, Zaidi, Syed H., primary, Toland, Amanda E., primary, Amitay, Efrat L., primary, Berndt, Sonja I., primary, Borozan, Ivan, primary, Chan, Andrew T., primary, Gallinger, Steven, primary, Gunter, Marc J., primary, Guinter, Mark A., primary, Harlid, Sophia, primary, Hampel, Heather, primary, Jenkins, Mark A., primary, Lin, Yi, primary, Moreno, Victor, primary, Newcomb, Polly A., primary, Nishihara, Reiko, primary, Ogino, Shuji, primary, Obón-Santacana, Mireia, primary, Parfrey, Patrick S., primary, Potter, John D., primary, Slattery, Martha L., primary, Steinfelder, Robert S., primary, Um, Caroline Y., primary, Wang, Xiaoliang, primary, Woods, Michael O., primary, Van Guelpen, Bethany, primary, Thibodeau, Stephen N., primary, Hoffmeister, Michael, primary, Sun, Wei, primary, Hsu, Li, primary, Buchanan, Daniel D., primary, Campbell, Peter T., primary, and Peters, Ulrike, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Tables 1-3 from High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes

Author

Woods, Michael O., primary, Hyde, Angela J., primary, Curtis, Fiona K., primary, Stuckless, Susan, primary, Green, Jane S., primary, Pollett, Aaron F., primary, Robb, J. Desmond, primary, Green, Roger C., primary, Croitoru, Marina E., primary, Careen, Amanda, primary, Chaulk, Jason A.W., primary, Jegathesan, Jegan, primary, McLaughlin, John R., primary, Gallinger, Steven S., primary, Younghusband, H. Banfield, primary, Bapat, Bharati V., primary, and Parfrey, Patrick S., primary

Published
2023
Full Text
View/download PDF

48. Association between Dietary Fiber Intake and Mortality among Colorectal Cancer Survivors: Results from the Newfoundland Familial Colorectal Cancer Cohort Study and a Meta-Analysis of Prospective Studies

Author

Zhao, Jing, primary, Zhu, Yun, additional, Du, Meizhi, additional, Wang, Yu, additional, Vallis, Jillian, additional, Parfrey, Patrick S., additional, Mclaughlin, John R., additional, Qi, Xiuying, additional, and Wang, Peizhong Peter, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results